Congenital Heart Diseases Market Trends, Size, Competitive Analysis and Forecast 2021-2027

The global congenital heart disease market is anticipated to grow at a significant CAGR of nearly 9.1% during the forecast period. Congenital heart disease also called congenital heart defect is a condition having abnormalities in heart structure from birth time. The disease affects the heart walls, valves, and blood vessels of the heart. Its symptoms include shortness of breath, arrhythmias, cyanosis, edema, tiring quickly upon exertion. The rise in the incidences of congenital heart disease has been witnessed over the years. For instance, as per the Centers for Disease Control and Prevention (CDC), congenital heart defects (CHDs) affect nearly 1% of?or about 40,000?births per year in the US. Approximately 1 in 100 babies are born with a heart defect in the US annually.

To Request a Sample of our Report on Congenital Heart Diseases Market: https://www.omrglobal.com/request-sample/congenital-heart-diseases-market

Moreover, 25% of babies with CHD have a critical CHD. Infants with critical CHDs generally need surgery or other invasive procedures within their first year of life. Several industry participants in developed countries are expected to introduce devices for the treatment of defects, as well as an increase in healthcare spending across emerging countries, is to create opportunities in the market during the forecast period. However, a lack of awareness regarding the condition is hindering the growth of the market.

(Get 15% Discount on Buying this Report)

A full Report of Congenital Heart Diseases Market is Available at: https://www.omrglobal.com/industry-reports/congenital-heart-diseases-market

Congenital Heart Diseases Market Segmentation

By Defect Type

· Heart Valve Defects

· Heart Wall Defects

· Blood Vessel Defects

By Diagnosis

· Echocardiogram

· Chest X-Ray

· MRI Scan

· Others

By Treatment

· Medications

· Implantable Heart Devices

· Catheter Procedures

· Open Heart Surgery

· Heart Transplant

By End-User

· Hospitals and Clinics

· Diagnostic Centres

· Others

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Company Profiles

· Abbott Laboratories

· AstraZeneca Plc

· Becton Dickson & Co.

· Bio-Rad Laboratories

· Boston Scientific Corp.

· Laboratory Corporation of America Holdings (LabCorp)

· F. Hoffmann-La Roche Ltd.

· Glaxosmithkline Plc

· Janssen Pharmaceuticals, Inc.

· Medtronic

· Viatris Inc.

· Novartis Ag

· Pfizer, Inc.

· Randox Laboratories Ltd.

· Response Biomedical Corporation

· Sanofi S.A.

· Siemens Healthineers

· Thermo Fisher Scientific Inc.

· Vericel Corporation

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/congenital-heart-diseases-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.